Sunitinib malate and Zometa drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Sunitinib malate (sunitinib malate) and Zometa (zoledronic acid). Common drug interactions include pleural effusion among females and osteonecrosis of jaw among males.
The phase IV clinical study analyzes what interactions people have when they take Sunitinib malate and Zometa. It is created by eHealthMe based on reports of 353 people who take the same drugs from the FDA, and is updated regularly.
What is Sunitinib malate?
Sunitinib malate has active ingredients of sunitinib malate. eHealthMe is studying from 9,160 Sunitinib malate users. Check the latest studies of Sunitinib malate.
What is Zometa?
Zometa has active ingredients of zoledronic acid. It is often used in multiple myeloma. eHealthMe is studying from 71,434 Zometa users. Check the latest studies of Zometa.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
353 people who take Sunitinib malate and Zometa together, and have interactions are studied.
What are the common drug interactions of Sunitinib malate and Zometa, by gender? *
What are the common drug interactions of Sunitinib malate and Zometa, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Sunitinib malate and Zometa?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Sunitinib malate (9,160 reports)
- Zometa (71,434 reports)
Browse all drug interactions of Sunitinib malate and Zometa:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Sunitinib malate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Zometa:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Sunitinib malate and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Zometa and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on sunitinib malate and zoledronic acid (the active ingredients of Sunitinib malate and Zometa, respectively), and Sunitinib malate and Zometa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Naproxen and Acute Upper Airway Obstruction for Women aged 50-59 - 2 seconds ago
- Naproxen and Choking for Women aged 50-59 - 2 seconds ago
- Naproxen and Airway Obstruction - Acute Upper for Women aged 50-59 - 3 seconds ago
- Could Metoprolol Tartrate cause Monoclonal Immunoglobulin Present? - 6 seconds ago
- Albuterol Sulfate and Cefdinir drug interactions for men aged 50-59 - 7 seconds ago
- Drug interactions of Lumigan and Pentasa - 13 seconds ago
- Drug interactions of Roxicet and Transderm Scop - 13 seconds ago
- Trental and Rotator Cuff Syndrome for Men aged 60+ - 16 seconds ago
- Could Meropenem cause Colitis - Pseudomembranous? - 20 seconds ago
- Could Meropenem cause Pseudomembranous Colitis? - 20 seconds ago